180 related articles for article (PubMed ID: 19904799)
41. Complex target-oriented total synthesis in the drug discovery process: the discovery of a highly promising family of second generation epothilones.
Rivkin A; Yoshimura F; Gabarda AE; Chou TC; Dong H; Tong WP; Danishefsky SJ
J Am Chem Soc; 2003 Mar; 125(10):2899-901. PubMed ID: 12617656
[TBL] [Abstract][Full Text] [Related]
42. A high-throughput model for screening anti-tumor agents capable of promoting polymerization of tubulin in vitro.
Hu W; Dong H; Li YZ; Hu XT; Han GJ; Qu YB
Acta Pharmacol Sin; 2004 Jun; 25(6):775-82. PubMed ID: 15169631
[TBL] [Abstract][Full Text] [Related]
43. Structural insight into the mechanism of epothilone A bound to beta-tubulin and its mutants at Arg282Gln and Thr274Ile.
Shi G; Wang Y; Jin Y; Chi S; Shi Q; Ge M; Wang S; Zhang X; Xu S
J Biomol Struct Dyn; 2012; 30(5):559-73. PubMed ID: 22731768
[TBL] [Abstract][Full Text] [Related]
44. The biology and medicinal chemistry of epothilones.
Wartmann M; Altmann KH
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):123-48. PubMed ID: 12678754
[TBL] [Abstract][Full Text] [Related]
45. Novel C2-C3' N-peptide linked macrocyclic taxoids. Part 1: Synthesis and biological activities of docetaxel analogues with a peptide side chain at C3'.
Larroque AL; Dubois J; Thoret S; Aubert G; Guénard D; Guéritte F
Bioorg Med Chem Lett; 2005 Nov; 15(21):4722-6. PubMed ID: 16165352
[TBL] [Abstract][Full Text] [Related]
46. Structural basis for drug resistance conferred by β-tubulin mutations: a molecular modeling study on native and mutated tubulin complexes with epothilone B.
Navarrete KR; Alderete JB; Jiménez VA
J Biomol Struct Dyn; 2015; 33(12):2530-40. PubMed ID: 26081685
[TBL] [Abstract][Full Text] [Related]
47. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.
Buey RM; Barasoain I; Jackson E; Meyer A; Giannakakou P; Paterson I; Mooberry S; Andreu JM; Díaz JF
Chem Biol; 2005 Dec; 12(12):1269-79. PubMed ID: 16356844
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis, and biological properties of highly potent epothilone B analogues.
Nicolaou KC; Sasmal PK; Rassias G; Reddy MV; Altmann KH; Wartmann M; O'Brate A; Giannakakou P
Angew Chem Int Ed Engl; 2003 Aug; 42(30):3515-20. PubMed ID: 12900969
[No Abstract] [Full Text] [Related]
49. Isolation and characterization of new epothilone analogues from recombinant Myxococcus xanthus fermentations.
Starks CM; Zhou Y; Liu F; Licari PJ
J Nat Prod; 2003 Oct; 66(10):1313-7. PubMed ID: 14575429
[TBL] [Abstract][Full Text] [Related]
50. Synthesis & antitumor activity of epothilones B and D and their analogs.
Cheng H; Huang G
Future Med Chem; 2018 Jun; 10(12):1483-1496. PubMed ID: 29788770
[TBL] [Abstract][Full Text] [Related]
51. Activity of epothilones.
Kolman A
Curr Opin Investig Drugs; 2005 Jun; 6(6):616-22. PubMed ID: 15988913
[TBL] [Abstract][Full Text] [Related]
52. A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone.
Wang M; Xia X; Kim Y; Hwang D; Jansen JM; Botta M; Liotta DC; Snyder JP
Org Lett; 1999 Jul; 1(1):43-6. PubMed ID: 10822530
[TBL] [Abstract][Full Text] [Related]
53. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
[TBL] [Abstract][Full Text] [Related]
54. C-15 thiazol-4-yl analogues of (E)-9,10-didehydroepothilone D: synthesis and cytotoxicity.
Hearn BR; Zhang D; Li Y; Myles DC
Org Lett; 2006 Jul; 8(14):3057-9. PubMed ID: 16805551
[TBL] [Abstract][Full Text] [Related]
55. Understanding tubulin/microtubule-taxane interactions: a quantitative structure-activity relationship study.
Hansch C; Verma RP
Mol Pharm; 2008; 5(1):151-61. PubMed ID: 18171015
[TBL] [Abstract][Full Text] [Related]
56. Synthesis, Biological Profiling and Determination of the Tubulin-Bound Conformation of 12-Aza-Epothilones (Azathilones).
Jantsch A; Nieto L; Gertsch J; Rodríguez-Salarichs J; Matesanz R; Jiménez-Barbero J; Díaz JF; Canales Á; Altmann KH
Molecules; 2016 Aug; 21(8):. PubMed ID: 27527129
[TBL] [Abstract][Full Text] [Related]
57. Computational comparison of microtubule-stabilising agents laulimalide and peloruside with taxol and colchicine.
Pineda O; Farràs J; Maccari L; Manetti F; Botta M; Vilarrasa J
Bioorg Med Chem Lett; 2004 Oct; 14(19):4825-9. PubMed ID: 15341932
[TBL] [Abstract][Full Text] [Related]
58. Structural insight into epothilones antitumor activity based on the conformational preferences and tubulin binding modes of epothilones A and B obtained from molecular dynamics simulations.
Jiménez VA; Alderete JB; Navarrete KR
J Biomol Struct Dyn; 2015; 33(4):789-803. PubMed ID: 24773261
[TBL] [Abstract][Full Text] [Related]
59. Application of ring-closing metathesis reactions in the synthesis of epothilones.
Rivkin A; Cho YS; Gabarda AE; Yoshimura F; Danishefsky SJ
J Nat Prod; 2004 Feb; 67(2):139-43. PubMed ID: 14987048
[TBL] [Abstract][Full Text] [Related]
60. Design and total synthesis of a superior family of epothilone analogues, which eliminate xenograft tumors to a nonrelapsable state.
Chou TC; Dong H; Rivkin A; Yoshimura F; Gabarda AE; Cho YS; Tong WP; Danishefsky SJ
Angew Chem Int Ed Engl; 2003 Oct; 42(39):4762-7. PubMed ID: 14562342
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
